# Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

> **NCT01574612** · PHASE3 · COMPLETED · sponsor: **Meda Pharmaceuticals** · enrollment: 54 (actual)

## Conditions studied

- Herpes Labialis

## Interventions

- **DRUG:** acyclovir/hydrocortisone cream

## Key facts

- **NCT ID:** NCT01574612
- **Lead sponsor:** Meda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-12
- **Final completion:** 2013-02
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2014-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01574612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01574612, "Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01574612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*